PPlenful automates pharmacy operations by offering a SaaS platform that connects with existing data sources like Electronic Health Records (EHRs) and Pharmacy Management Systems (PMSs) to streamline workflows. Its system centralizes data and uses a mix of AI and rules-based logic, along with proprietary OCR, to automate manual tasks and reduce errors. The platform provides pre-configured workflows built from industry best practices and requires zero-code integration, making it easy to deploy within healthcare settings. Compared to generic automation tools, Plenful focuses specifically on healthcare and pharmacy operations, helping clients improve financial, operational, and care-related ROI through increased efficiency and data accuracy. The company’s goal is to lessen the burden on healthcare staff, optimize staffing, and offer clear transparency into operations.
Work here?Claim your company
Industries
Company Size
51-200
Company Stage
Series B
Total Funding
$76M
Headquarters
San Francisco, CA
Founded
2020
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$76M
Above
Industry Average
Funded Over
3 Rounds
Industry standards
Plenful and Cencora partner to power the future of pharmacy. Founder & CEO Cencora's Accelerate Pharmacy Solutions is collaborating with Plenful as part of its expanded technology ecosystem. Its work together spans intake authorization, 340B optimization, rebate and MFP management, and other critical pharmacy workflows. Read the full announcement here. Today, Cencora announced an expansion of its Accelerate Pharmacy Solutions technology ecosystem, highlighting its ongoing collaboration with Plenful and a shared goal: fewer barriers between patient and therapy. This announcement reflects two years of hard work alongside the Cencora team and the strength of the technology Plenful has built at Plenful. Together, Plenful is combining its AI platform with deep pharmacy expertise to solve complex problems and deliver meaningful value to pharmacy teams and their patients. This milestone is a chance to share what that collaboration makes possible for its customers, and why I'm excited for what's ahead. Connecting coverage information with best-in-class AI. Getting a patient started on therapy requires confirming insurance coverage, gathering clinical documentation, and securing the required prior authorization. The information needed to make those decisions and the work required to act on them have historically been disparate and disorganized. When patient information and platform tools are disconnected, patients wait longer for the care they need. That's where its partnership comes in. Plenful leverages Cencora's eBenefit Services to help providers and pharmacy teams validate access, out-of-pocket costs, formulary, and prior authorization information within a single workflow. Plenful is seeing customers reduce intake and PA processing time by more than 75%. For covered entities, its collaboration also spans 340B compliance audits, missed savings identification, and MFP and 340B rebate management. These workflows augment lean 340B teams and positively impact pharmacy financial performance as manufacturer and regulatory requirements continue to evolve. Plenful customers like Mercy Medical Center have reported as much as 33x audit capacity increases with Plenful. The broader Cencora announcement includes Cencora Connect, a new digital front door designed to give specialty pharmacy and infusion teams more centralized access to Cencora tools, services, and partner-enabled technology, including Plenful's AI workflow automation. Stay ahead of what's ahead. At Plenful, Plenful is building indispensable AI for the future of pharmacy. Working alongside Cencora and Accelerate Pharmacy Solutions keeps that mission grounded in the needs of its shared customers, from simplifying intake authorization to identifying missed 340B savings and streamlining rebate management. As therapies, manufacturer requirements, and reimbursement models evolve, pharmacy teams need technology that stays ahead of what's next. Its goal is to be the trusted partner that helps them anticipate those changes and respond with confidence. Thank you to David Tinsley and its partners at Cencora across the Accelerate Pharmacy Solutions team, its colleagues at Plenful, and the hundreds of customers who make this work possible. I'm proud of what Plenful has built together and can't wait for what's next as Plenful continue deepening its integrations and joint solutions for specialty teams. If you're a Cencora and Accelerate Pharmacy Solutions customer, Plenful'd love to explore how this partnership can help your team stay ahead of what's ahead. Let's connect. Explore Plenful's AI platform and its expanded Cencora partnership.
Plenful has launched Rebate Intelligence, an AI-powered solution that automates rebate submission and reconciliation for the US Health Resources and Services Administration's revised 340B Rebate Model Pilot Program. More than 30 enterprise health systems have contracted with Plenful ahead of the programme's 1 January 2027 launch. The 340B Drug Pricing Program helps nearly half of US hospitals stretch resources for underserved patients. Under HRSA's revised model, covered entities will pay wholesale acquisition cost upfront on certain drugs, then submit claims for reimbursement. The pilot covers roughly $5.5 billion in annual 340B purchases, putting an estimated $2.75 billion in savings at stake. Rebate Intelligence extends Plenful's Claim Reconciliation Management suite, giving pharmacy and finance teams a unified platform for managing rebates and refunds across programmes.
Where AI is working for 340B programs: lessons from Coalition. 340B teams are running lean while compliance and regulatory scrutiny only tighten. Manufacturer data demands are expanding, MFP reconciliation has landed on already-stretched teams, and experienced 340B talent is hard to find and harder to keep. At 340B Health's Summer Coalition Conference, Plenful's SVP of Pharmacy Tim L'Hommedieu made an encouraging case for AI in 340B programs. Instead of piling more manual work onto stretched teams, AI is already safeguarding compliance, surfacing missed savings, and speeding up decisions for 340B programs today. Where AI creates the most impact. Across the programs that have adopted AI, the impact tends to concentrate in three places. 1. Safeguarding 340B compliance. AI can monitor for documentation gaps, audit exposure, and compliance risk continuously, so a program stays defensible without a person manually checking every claim. Instead of sampling a fraction of claims and hoping the rest hold up, a program can screen everything and catch exposure before an auditor does. As manufacturers tighten their reporting protocols, that always-on layer of protection matters more, not less. 2. Surfacing missed 340B savings. AI identifies savings that manual processes can't reach at scale, from uncaptured referrals to misclassified claims. It also catches value that quietly slips away, like therapies that were administered but never made it onto a claim. With a rebate model looming, that kind of financial oversight becomes even more critical. 3. Accelerating decision-making. AI absorbs the reasoning load of pattern recognition and data synthesis, so teams reach decisions faster and spend less of their day on tedious, low-value work. The point isn't to make the decision for anyone. It's to hand staff a clear, organized picture so the judgment call is the only part left to make. Referral capture: investigating what manual review can't reach. A large share of eligible savings hides in EHR documentation that's challenging to investigate at scale: progress notes, discharge summaries, or long PDFs where a person would have to physically comb through every line to find the evidence that connects a prescription to an eligible encounter. Most health systems don't have the resources to invest here meaningfully, so the savings are simply left on the table. AI tools like its Referral Agent solution can scan that documentation at roughly 98 times the volume a manual team can manage, then point staff to the highest-value opportunities first, ranked by drug cost and referral specialty. The compliance loop closes on its own: documentation is generated and routed back to referring providers through EHR integrations, building a defensible, audit-ready record automatically. "Plenful combs through the chart, identifies key words and phrases, and links all the pieces together to show the closed loop referral pathway. What's even better - it goes beyond detecting referrals to generating documentation you can stand up in an audit." Chief Pharmacy Officer Leading Mid-Atlantic Academic Medical Center MFP and rebate reconciliation: closing a 20% gap. Maximum Fair Price reconciliation is manual, and extraordinarily tedious. Plenful customers are reporting that as much as 20% of expected MFP refunds are missing, underpaid, or absent from the Medicare Transaction Facilitator entirely. Recovering them means reconciling across multiple platforms, filing good faith inquiries before deadlines close, and chasing outliers one at a time. Automation changes the math here. Its MFP Intelligence solution, featuring GFI Agent, organizes and submits the required data elements to manufacturers accurately and completely, eliminating the manual assembly across fragmented sources that delays or forfeits payments. It surfaces missing refunds, duplicate situations, and delayed reimbursements, then runs the good faith inquiry (GFI) and ESP submission workflow to recover them automatically. And finance and compliance leaders get real-time visibility, reconciling claims, refunds, and missing amounts in a single view instead of scattered spreadsheets. How to adopt AI in your 340B program: 4 change-management principles. The most common reason AI adoption fails in 340B has nothing to do with the technology. It's skipping the groundwork. Tim's advice for where to begin came down to four principles. * Map before you build. Define the current-state workflow before layering automation on top of it, or you'll just automate confusion. * Define success before you go live. Set baseline metrics upfront, and make sure your systems can actually report on the outcomes you care about. * Start narrow and prove impact fast. Pick one high-visibility use case, show the value, then expand. Momentum matters more than scope. * Build champions across functions. Compliance leads, 340B analysts, and CFOs each need a different reason to care. AI adoption is a team sport. AI gives scarce, experienced staff their time back for the work that needs their expert judgment, and takes the repetitive, tedious tasks off their plates. For 340B teams, that means faster savings recovery, reduced staff burnout, and more room to serve the patients who depend on the program. Explore AI solutions for your pharmacy team
Plenful Announces GFI Agent to Automatically Close the Loop on Missing MFP Refunds. July 8, 2026 San Francisco Biotechnology Network News News, Syndication Comments Off on Plenful Announces GFI Agent to Automatically Close the Loop on Missing MFP Refunds GFI Agent automates Good Faith Inquiry submission and ESP reporting, helping pharmacy teams recover every refund owed without the manual chase. SAN FRANCISCO, July 8, 2026 /PRNewswire/ - Plenful, the leading AI workflow automation platform for pharmacy teams, today announced GFI Agent, a... Discover more Tourist Destinations Geographic Reference Demographics
Plenful has launched Referral Agent, the first AI solution designed to identify and capture referral-based savings within the 340B Drug Pricing Program. At a leading Mid-Atlantic academic medical center, the platform expanded referral claim review from 130 claims monthly to 12,700, a 98-fold increase, with average savings of more than $1,850 per claim. Referral Agent uses large language models to analyse structured and unstructured electronic health record data, including clinical notes and PDFs, to match referrals to downstream claims. The system provides auditable records with source documents and confidence signals for regulatory compliance. The platform joins Plenful's 340B Audit and Optimisation suite, currently used by over 95 healthcare organisations. The 340B program covers nearly 50% of US hospitals and generates billions in savings for underserved patient care.
Find jobs on Simplify and start your career today
Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs
Industries
Company Size
51-200
Company Stage
Series B
Total Funding
$76M
Headquarters
San Francisco, CA
Founded
2020
Find jobs on Simplify and start your career today
Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs